Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Glioma
×
Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin
×
Clear all
Filters
3
NCT02655601
2025-06-08
BMX-HGG
BioMimetix JV, LLC
Phase 1/2
Completed
177 enrolled
34 charts